Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test

Overview of attention for article published in Journal of Hematology & Oncology, August 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 3 news outlets

twitter: 4 X users

Citations

dimensions_citation: 62 Dimensions

Readers on

mendeley: 34 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

New Publication Highlights First Prospective Performance Assessment of the DecisionDx-Melanoma Gene Expression Profile Test - Press Release

Digital Journal, 05 Sep 2017

FRIENDSWOOD, Texas--(Business Wire)--Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment…

Castle Biosciences Release: New Publication Highlights First Prospective Performance Assessment Of The Decisiondx-Melanoma Gene Expression Profile Test

Biospace, 05 Sep 2017

Multi-center study of 322 patients confirms prognostic accuracy and performance FRIENDSWOOD, Texas--( BUSINESS WIRE )--Castle…

Castle Biosciences Release New Publication Highlights First Prospective Performance Assessment Of The Decisiondx Melanoma Gene Expression Profile Test

Device Space, 05 Sep 2017

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.